In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
2016 · npj Vaccines · 136 citations
https://doi.org/10.1038/npjvaccines.2016.21
K
Kar Muthumani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
202
Papers
6.6K
Citations
43
h-index
119
i10-index
Kar Muthumani is an academic researcher from The Wistar Institute. The author has contributed to research in topics: Immunotherapy and Immune Responses & HIV Research and Treatment & Mosquito-borne diseases and control. The author has an h-index of 43, co-authored 172 publications.
ORCID: 0000-0002-6807-2065Papers by this author
worksDNA vaccination protects mice against Zika virus-induced damage to the testes
2017 · Nature Communications · 93 citations
https://doi.org/10.1038/ncomms15743
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
2018 · Cell Reports · 50 citations
https://doi.org/10.1016/j.celrep.2018.10.062
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
2017 · npj Vaccines · 48 citations
https://doi.org/10.1038/s41541-017-0020-x
Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab
2013 · Human Vaccines & Immunotherapeutics · 46 citations
https://doi.org/10.4161/hv.26498
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity
2019 · JCI Insight · 40 citations
https://doi.org/10.1172/jci.insight.126086
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat